ARID5B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.561200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.620600E-01
Normal-vs-Stage2
2.851800E-01
Normal-vs-Stage3
1.060570E-01
Normal-vs-Stage4
8.747800E-01
Stage1-vs-Stage2
7.730800E-01
Stage1-vs-Stage3
6.333400E-01
Stage1-vs-Stage4
3.935600E-01
Stage2-vs-Stage3
4.926600E-01
Stage2-vs-Stage4
3.486800E-01
Stage3-vs-Stage4
2.626000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.499600E-01
Normal-vs-AfricanAmerican
6.772400E-01
Normal-vs-Asian
3.090000E-02
Caucasian-vs-AfricanAmerican
3.663000E-01
Caucasian-vs-Asian
1.017240E-01
AfricanAmerican-vs-Asian
7.619600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.940570E-01
Normal-vs-Female
3.641200E-01
Male-vs-Female
1.419820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.134600E-01
Normal-vs-Age(41-60Yrs)
4.665600E-01
Normal-vs-Age(61-80Yrs)
2.158400E-01
Normal-vs-Age(81-100Yrs)
5.343700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.365200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.938400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.084400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.275700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.647700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.132200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.530200E-02
Normal-vs-Daily Drinker
1.965820E-01
Normal-vs-Weekly Drinker
2.019800E-01
Normal-vs-Occasional Drinker
5.258300E-02
Normal-vs-Social Drinker
6.799400E-01
Non Drinker-vs-Daily Drinker
4.165600E-01
Non Drinker-vs-Weekly Drinker
2.965200E-01
Non Drinker-vs-Occasional Drinker
5.171600E-01
Non Drinker-vs-Social Drinker
1.730570E-01
Daily Drinker-vs-Weekly Drinker
8.081600E-01
Daily Drinker-vs-Occasional Drinker
8.254800E-01
Daily Drinker-vs-Social Drinker
3.396200E-01
Weekly Drinker-vs-Occasional Drinker
5.993600E-01
Weekly Drinker-vs-Social Drinker
4.867200E-01
Occasional Drinker-vs-Social Drinker
2.952200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.122600E-01
Normal-vs-Grade 2
2.455400E-01
Normal-vs-Grade 3
2.651200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.911390E-01
Grade 1-vs-Grade 3
8.914200E-01
Grade 1-vs-Grade 4
5.122600E-01
Grade 2-vs-Grade 3
8.717600E-02
Grade 2-vs-Grade 4
2.455400E-01
Grade 3-vs-Grade 4
2.651200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.753600E-01
Normal-vs-NonDiabetic
1.104020E-01
Diabetic-vs-NonDiabetic
1.092980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.493020E-01
Normal-vs-NoPancreatitis
2.002800E-01
Pancreatitis-vs-NoPancreatitis
9.690600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.430200E-01
Normal-vs-N1
2.859600E-01
N0-vs-N1
4.575000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.286100E-02
Normal-vs-TP53-NonMutant
3.188000E-01
TP53-Mutant-vs-TP53-NonMutant
4.473600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
